<DOC>
	<DOCNO>NCT02529163</DOCNO>
	<brief_summary>As late Integrated Care Pathways ( ICPs ) show improve quality care medical field special attention give mental health particular . One aspect metal health see incorporation ICPs area schizophrenia . Late life Schizophrenia ( LLS ) define suffer schizophrenia 50 year age old . The LLS-ICP study look efficacy ICP late life schizophrenia versus treatment usual ( TAU ) . Participants LLS psychotic symptom predefined threshold randomly assign TAU group ICP group . The primary outcome measure reduction symptom severity measure clinical global impression severity scale ( CGI-S ) brief psychiatric rating scale ( BPRS ) . If successful , study provide strong evidence implement LLS-ICP across different inpatient outpatient setting .</brief_summary>
	<brief_title>Evaluating Efficacy Late-Life Schizophrenia Integrated Care Pathway Treat Acute Psychotic Symptoms</brief_title>
	<detailed_description>This study aim investigate whether Late-Life Schizophrenia-Integrated Care Pathway ( LLS-ICP ) superior treatment usual ( TAU ) treatment psychotic symptom patient schizophrenia schizoaffective disorder . The investigator hypothesize LLS-ICP superior TAU result 1.higher rate response , 2. short time response , 3. less side effect , 4. good functional outcome . The LLS-ICP study first randomize control study ass efficacy ICP patient schizophrenia schizoaffective disorder region . If successful , lead development new innovative approach health care delivery patient chronic schizophrenia schizoaffective disorder within institution also sit community . The nature ICPs algorithmic systematic provide assessment treatment render ideal disseminate medical practice outside institution develop . These setting include primary care clinic , supportive living environment , long-term care home patient chronic schizophrenia schizoaffective disorder care .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Ziprasidone</mesh_term>
	<mesh_term>Clozapine</mesh_term>
	<mesh_term>Paliperidone Palmitate</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>All race ethnicity Meets DSMIV TR ( Diagnostic Statistical Manual Version 4 Text Revision ) criteria current diagnosis Schizophrenia clinically unstable acute episode define CGI severity score great 3 BPRS think disorder subscale score high 6 ( total score ) . Willingness ability speak English Willingness provide inform consent proxy Corrected visual ability enable read newspaper headline correct hear capacity adequate respond raise conversational voice . Diagnosis bipolar disorder , current major depressive episode acutely psychotic episode secondary nonschizophrenic disorder Meets diagnostic criterion substance use dependence within 6 month prior initial assessment except caffeine nicotine</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Integrated Care Pathway</keyword>
	<keyword>Acute Psychotic Episode</keyword>
	<keyword>Randomised Control Trial</keyword>
</DOC>